Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner +14 more
wiley +1 more source
Erratum to "Integrated Single-Step Terahertz Metasensing for Simultaneous Detection Based on Exosomal Membrane Proteins Enables Pathological Typing of Gastric Cancer". [PDF]
Jia Q +11 more
europepmc +1 more source
Objective We evaluated the role of 25‐hydroxyvitamin D (25[OH]D), prednisone, and other risk factors for bone mineral density (BMD) loss and osteoporosis in systemic lupus erythematosus (SLE). Methods We calculated the association between 25(OH)D levels and other potential risk factors and BMD measures (spine T scores) and osteoporosis (defined as a T ...
Nima Madanchi +4 more
wiley +1 more source
Evaluating the effectiveness and impact of the 'HSE Spark' Innovation Programme: a qualitative study protocol. [PDF]
Kessie T +5 more
europepmc +1 more source
Linking Symptom Phenotypes to Patterns of White Matter Injury in Mild Traumatic Brain Injury: A Latent Class Analysis. [PDF]
Chung S +13 more
europepmc +1 more source
Developing a national strategy to support implementation of reablement for community-dwelling people living with dementia. [PDF]
O'Connor CM +10 more
europepmc +1 more source
It's Not Just About the Tools: Emotionally Responsive GenAI Education. [PDF]
Samuel A, Merkebu J.
europepmc +1 more source
Digital innovation and carbon intensity: Dual mediating role of technological spillover and industrial agglomeration. [PDF]
Wu S, Li Y, Zhou X.
europepmc +1 more source
Environmental stewardship and robotic surgery: innovation without compromise. [PDF]
Jacob MO +4 more
europepmc +1 more source
Related searches:
Journal Article ; Review ; info:eu-repo/semantics ...
Arvanitakis, Marianna, Devière, Jacques
openaire +2 more sources

